Sanuwave Health appoints Coyle COO, removes Stegagno; terminates President Walko

SANUWAVE Health, Inc.

Daniel Coyle appointed COO effective Sept 25, 2025; previously VP of Engineering.
Former COO Peter Stegagno removed, appointed Chief Regulatory Officer; no longer an executive officer.
President Andrew Walko terminated without cause effective Oct 24, 2025; no new President planned.
Coyle's base salary set at $225,000, bonus at 40% of salary, and options for 60,000 shares vesting quarterly.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.